Skip to search formSkip to main contentSkip to account menu

dopexamine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
OBJECTIVES Vasopressor-induced vasoconstriction may compromise renal and splanchnic blood flow in patients with septic shock… 
2004
2004
Background  The synthetic β2‐adrenergic and dopaminergic agonist dopexamine is supposed to prevent splanchnic hypoperfusion in… 
2002
2002
Objective To compare the effects of dopamine and dopexamine on gastric mucosal oxygenation during mechanical ventilation without… 
1999
1999
Liver blood flow is reduced after cardiopulmonary bypass (CPB) and both dopamine and dopexamine are used to overcome this. This… 
1995
1995
Gastric tonometry was used to study the possible effect of dopexamine infusion on a low calculated intramucosal pH (pHi) as a… 
1989
1989
The results of the present study show that the reduction of the total number of β adrenoceptors affected the β1-adrenoceptor… 
1988
1988
Ten patients with chronic heart failure were given a continuous infusion of dopexamine after an initial stage of dose titration… 
1987
1987
Dopexamine (FPL 60278) is a new vasodilator possessing both postjunctional dopaminergic and β2-adrenoceptor agonist actions. Its… 
1986
1986
Dopexamine increases inotropic state and rate of relaxation independent of changes in heart rate. Dopexamine has a chronotropic…